The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy

Autor: Moore, C., Kosgodage, U., Lange, S., Inal, J.M.

There is an urgent need to develop new combination therapies beyond existing surgery, radio- and chemo-therapy, perhaps initially combining chemotherapy with the targeting specificities of immunotherapy. For this, strategies to limit inflammation and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::94139032c8d64794c4367cf98fd39456
https://westminsterresearch.westminster.ac.uk/download/d2d28a8912a3b88500c96e19c0f6625d049f79c3f1589ef7575af941531f3b8b/1417849/Moore_et_al-2017-International_Journal_of_Cancer-1.pdf

The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy.

Autor: Moore C; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom., Kosgodage U; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom., Lange S; University College London School of Pharmacy, London, WC1N 1AX, United Kingdom.; Department of Biomedical Sciences, University of Westminster, London, United Kingdom., Inal JM; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom.

Publikováno v: International journal of cancer [Int J Cancer] 2017 Aug 01; Vol. 141 (3), pp. 428-436. Date of Electronic Publication: 2017 Mar 16.